Literature DB >> 20363606

Predictors of mortality in hospitalized patients with acute exacerbation of bronchiectasis.

James D Finklea1, Gul Khan, Sheree Thomas, Juhee Song, Dennis Myers, Alejandro C Arroliga.   

Abstract

BACKGROUND: In-hospital and long term outcomes of patients admitted to the hospital for acute exacerbation of bronchiectasis (AEB) has been evaluated in only a limited fashion. The resulting debilitation after an AEB can increase mortality. This study aims to evaluate the factors associated with mortality in patients admitted with an acute exacerbation of bronchiectasis (AEB).
METHODS: All charts of the patients admitted between 2003 and 2006 with an AEB were reviewed through an electronic database. Demographics, sputum cultures, pulmonary functions tests and other factors associated with long-term mortality were examined. The social security death index was used to determine long term mortality (http://ssdi.genealogy.rootsweb.com).
RESULTS: Forty-three patients (13 men and 30 women) with a mean age of 71.8+/-11.8 were studied. The hospital mortality was 9% and one-year mortality was 30% with a median survival of 46.6 months. Variables associated with mortality were male gender (female vs. male (HR), 0.36; (CI), 0.14-0.98; p=0.045), use of systemic steroids (with vs. without steroids HR, 3.12; CI 1.08-9.02; p=0.036), decreased FEV(1.0)% predicted (HR, 0.96; CI 0.92-0.999; p=0.042), elevated creatinine (HR, 2.36; CI 1.093-5.10; p=0.029), history of smoking (HR, 0.283; CI 0.097-0.825; p=0.021), and mechanical ventilation (HR, 66.011; CI 6.64-656.76; p=0.0004).
CONCLUSIONS: Male gender, elevated creatinine, decreased FEV(1.0)% predicted, mechanical ventilation, history of smoking, and acute use of systemic steroids during the hospitalization were associated with an increased risk of mortality. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20363606     DOI: 10.1016/j.rmed.2009.11.021

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  14 in total

1.  Dose-related effect of smoking on mortality in critically ill patients: a multicentre cohort study.

Authors:  Kwok M Ho; Graeme Hart; David Austin; Mike Hunter; John Botha; Shaila Chavan
Journal:  Intensive Care Med       Date:  2011-03-11       Impact factor: 17.440

Review 2.  Diagnosis and management of bronchiectasis.

Authors:  Maeve P Smith
Journal:  CMAJ       Date:  2017-06-19       Impact factor: 8.262

3.  Impact of traffic related air pollution indicators on non-cystic fibrosis bronchiectasis mortality: a cohort analysis.

Authors:  Pieter C Goeminne; Esmee Bijnens; Ben Nemery; Tim S Nawrot; Lieven J Dupont
Journal:  Respir Res       Date:  2014-09-03

4.  Prognostic Factors in Adult Patients with Non-Cystic Fibrosis Bronchiectasis.

Authors:  Betina Charvet Machado; Patrícia Santos Jacques; Louise Piva Penteado; Paulo de Tarso Roth Dalcin
Journal:  Lung       Date:  2018-09-25       Impact factor: 2.584

Review 5.  Suspecting non-cystic fibrosis bronchiectasis: What the busy primary care clinician needs to know.

Authors:  Diego J Maselli; Bravein Amalakuhan; Holly Keyt; Alejandro A Diaz
Journal:  Int J Clin Pract       Date:  2017-02       Impact factor: 2.503

6.  Brazilian consensus on non-cystic fibrosis bronchiectasis.

Authors:  Mônica Corso Pereira; Rodrigo Abensur Athanazio; Paulo de Tarso Roth Dalcin; Mara Rúbia Fernandes de Figueiredo; Mauro Gomes; Clarice Guimarães de Freitas; Fernando Ludgren; Ilma Aparecida Paschoal; Samia Zahi Rached; Rosemeri Maurici
Journal:  J Bras Pneumol       Date:  2019-08-12       Impact factor: 2.624

7.  ECG Abnormalities in Patients with Acute Exacerbation of Bronchiectasis and Factors Associated with High Probability of Abnormality.

Authors:  Fatima Alhamed Alduihi
Journal:  Pulm Med       Date:  2021-07-05

8.  The short and long term effects of exercise training in non-cystic fibrosis bronchiectasis--a randomised controlled trial.

Authors:  Annemarie L Lee; Catherine J Hill; Nola Cecins; Sue Jenkins; Christine F McDonald; Angela T Burge; Linda Rautela; Robert G Stirling; Philip J Thompson; Anne E Holland
Journal:  Respir Res       Date:  2014-04-15

9.  Risk factors for multidrug-resistant pathogens in bronchiectasis exacerbations.

Authors:  Rosario Menéndez; Raúl Méndez; Eva Polverino; Edmundo Rosales-Mayor; Isabel Amara-Elori; Soledad Reyes; José Miguel Sahuquillo-Arce; Laia Fernández-Barat; Victoria Alcaraz; Antoni Torres
Journal:  BMC Infect Dis       Date:  2017-09-30       Impact factor: 3.090

10.  Bronchiectasis in patients hospitalized with acute exacerbation of COPD in Spain: Influence on mortality, hospital stay, and hospital costs (2006-2014) according to gender.

Authors:  Gema Sánchez-Muñoz; Ana Lopez-de-Andrés; Valentín Hernández-Barrera; Rodrigo Jiménez-García; Fernando Pedraza-Serrano; Luis Puente-Maestu; Javier de Miguel-Díez
Journal:  PLoS One       Date:  2019-01-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.